Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK. - Tsai, Kun-Ling; Hsieh, Pei-Ling; Chou, Wan-Ching; Cheng, Hui-Ching; Huang, Yu-Ting; Chan, Shih-Hung (Cell & Bioscience, 2021)